• Maguar Capital agreed to acquire a majority stake in Schlafender Hase, a provider of content-verification software for pharma and medical technology.
• Wieland Capital and a co-founder will reinvest, remaining significant shareholders alongside Maguar.
• Schlafender Hase’s deterministic software is used to detect and eliminate errors in regulated documentation and packaging workflows.
• The business was founded in 2001, employs about 40 people, and sells its TVT product across on-premise deployments and cloud applications.
• Strategy centers on expanding international go-to-market and developing the web-based platform, with plans to enter adjacent regulated sectors.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Maguar Capital Management GmbH published the original content used to generate this news brief on August 12, 2026, and is solely responsible for the information contained therein.